MedPath

Efficacy Of Haridradi Anjana In Kaphaja Abhisyanda wsr Vernal Keratoconjunctivitis

Not Applicable
Conditions
Health Condition 1: H00-H59- Diseases of the eye and adnexa
Registration Number
CTRI/2020/06/025919
Lead Sponsor
ttrakhand Ayurveda University Harrawala dehradun
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1-Patients aged between 8-20 years.

2-Patients, presenting with signs and symptoms of Kaphaja Abhishyanda /Vernal keratoconjunctivitis.

3-Sex -Either sex

Exclusion Criteria

1-Patients having other eye diseases like blepharitis, trachoma, dry eye, corneal xerosis,phlyctenular keratoconjunctivitis, corneal ulcer, dacryocystitis, and infective conjunctivitis. 2-Patients suffering from other systemic disease & metabolic disorders.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cured: 91% relief in signs and symptoms and no recurrence during follow up study. <br/ ><br>2. Marked Improvement: 76-90% improvement in signs and symptoms. <br/ ><br>3. Moderate Improvement: 51-75% improvement in signs and symptoms. <br/ ><br> 4. Mild Improvement: 26-50% improvement in signs and symptoms. <br/ ><br> 5. Unchanged: Up to or25% relief in signs and symptoms. <br/ ><br>Timepoint: 15 April 2021 <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
excerbation in sign and symptomTimepoint: 1 month
© Copyright 2025. All Rights Reserved by MedPath